申请人:Sandoz Ltd.
公开号:US04067873A1
公开(公告)日:1978-01-10
This invention provides compounds of formula I, ##STR1## wherein R is alkyl of 3 to 7 carbon atoms; cycloalkyl of 3 to 7 carbon atoms; cycloalkyl of 3 to 7 carbon atoms monosubstituted with alkyl of 1 to 4 carbon atoms; .alpha.-dialkylpropinyl of 5 to 9 carbon atoms; .alpha.-dialkylallyl of 5 to 9 carbon atoms; hydroxyalkyl of 2 to 7 carbon atoms, the hydroxy group thereof being separated by at least two carbon atoms from the nitrogen atom to which R is bound; phenethyl; phenethyl mono- or disubstituted in the phenyl residue independently when di-substituted with halogen of atomic number from 9 to 35, alkyl of 1 to 4 carbon atoms or unbranched alkoxy of 1 to 4 carbon atoms; or adamantyl; and Either R.sub.1 is phenyl and R.sub.2 is hydrogen; Or R.sub.1 is alkyl of 1 to 4 carbon atoms or halogen of atomic number from 9 to 35 and R.sub.2 is unbranched alkoxy of 1 to 4 carbon atoms or halogen of atomic number from 9 to 35, with the general proviso that the 8-position of the isoquinoline is unsubstituted and any halogen substituent which may be present in the 3- or 4- position is other than fluorine, Useful for treating coronary diseases, arrhythmia, hyperlipoidemia and hyperglycemia.
该发明提供了I式化合物,其中R为3至7个碳原子的烷基;3至7个碳原子的环烷基;3至7个碳原子的单取代烷基的环烷基;5至9个碳原子的α-二烷基丙烯基;5至9个碳原子的α-二烷基烯丙基;2至7个碳原子的羟基烷基,其中其羟基与R结合的氮原子至少相隔两个碳原子;苯乙基;苯乙基在苯基残基中单取代或双取代,当双取代时,取代基为原子序数为9至35的卤素,1至4个碳原子的烷基或1至4个碳原子的直链烷氧基;或金刚烷基;并且R1是苯基且R2是氢;或R1是1至4个碳原子的烷基或原子序数为9至35的卤素,R2是1至4个碳原子的直链烷氧基或原子序数为9至35的卤素,一般而言,异喹啉的8位未取代,3位或4位可能存在的任何卤素取代基均不是氟,用于治疗冠心病、心律失常、高脂血症和高血糖症。